Luyan Pharma Co.,Ltd. (SHE:002788)
China
· Delayed Price · Currency is CNY 15.10
+0.29 (1.96%)
Mar 10, 2026, 2:15 PM CST
Luyan Pharma Revenue
Luyan Pharma had revenue of 5.46B CNY in the quarter ending September 30, 2025, with 6.81% growth. This brings the company's revenue in the last twelve months to 20.91B, up 2.09% year-over-year. In the year 2024, Luyan Pharma had annual revenue of 20.47B with 3.15% growth.
Revenue (ttm)
20.91B
Revenue Growth
+2.09%
P/S Ratio
0.28
Revenue / Employee
3.73M
Employees
5,602
Market Cap
5.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 20.47B | 625.23M | 3.15% |
| Dec 31, 2023 | 19.85B | 383.03M | 1.97% |
| Jan 1, 2023 | 19.46B | 1.92B | 10.93% |
| Dec 31, 2021 | 17.55B | 2.01B | 12.94% |
| Dec 31, 2020 | 15.54B | 526.42M | 3.51% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ShuYu Civilian Pharmacy Corp. | 9.94B |
| Yixintang Pharmaceutical Group | 17.41B |
| Cachet Pharmaceutical | 19.99B |
| Anhui Huaren Health Pharmaceutical | 5.15B |
| LBX Pharmacy Chain Joint Stock Company | 22.20B |
| Sichuan Hezong Medicine Easy-to-buy Pharmaceutical | 4.39B |
| Jianzhijia Pharmaceutical Chain Group | 9.10B |
| Shanghai No.1 Pharmacy | 2.09B |